BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 30903725)

  • 21. Early Allograft Dysfunction After Live Donor Liver Transplantation: It's Time to Redefine?
    Pamecha V; Pattnaik B; Sinha PK; Patil NS; Sasturkar SV; Mohapatra N; Kumar G; Choudhury A; Sarin SK
    J Clin Exp Hepatol; 2022; 12(1):101-109. PubMed ID: 35068790
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coexistence of Bilirubin ≥10 mg/dL and Prothrombin Time-International Normalized Ratio ≥1.6 on Day 7: A Strong Predictor of Early Graft Loss After Living Donor Liver Transplantation.
    Okamura Y; Yagi S; Sato T; Hata K; Ogawa E; Yoshizawa A; Kamo N; Yamashiki N; Okajima H; Kaido T; Uemoto S
    Transplantation; 2018 Mar; 102(3):440-447. PubMed ID: 28968350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of the postoperative cholesterol in early allograft dysfunction and survival after living donor liver transplantation.
    Yang J; Wang HQ; Yang JY; Wen TF; Li B; Wang WT; Yan LN
    Hepatobiliary Pancreat Dis Int; 2017 Dec; 16(6):610-616. PubMed ID: 29291780
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation of Different Serum Biomarkers with Prediction of Early Pancreatic Graft Dysfunction Following Simultaneous Pancreas and Kidney Transplantation.
    Jahn N; Voelker MT; Laudi S; Stehr S; Schneeberger S; Brandacher G; Sucher E; Rademacher S; Seehofer D; Sucher R; Hau HM
    J Clin Med; 2022 May; 11(9):. PubMed ID: 35566689
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High neutrophil-lymphocyte ratio indicates poor prognosis for acute-on-chronic liver failure after liver transplantation.
    Lin BY; Zhou L; Geng L; Zheng ZY; Jia JJ; Zhang J; Yao J; Zheng SS
    World J Gastroenterol; 2015 Mar; 21(11):3317-24. PubMed ID: 25805939
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inflammation-based Prognostic Score in Patients with Living Donor Liver Transplantation for Hepatocellular Carcinoma.
    Harimoto N; Yoshizumi T; Shimagaki T; Nagatsu A; Motomura T; Harada N; Okabe H; Itoh S; Ikegami T; Uchiyama H; Soejima Y; Maehara Y
    Anticancer Res; 2016 Oct; 36(10):5537-5542. PubMed ID: 27798927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. D-MELD as a predictor of early graft mortality in adult-to-adult living-donor liver transplantation.
    Ikegami T; Imai D; Wang H; Yoshizumi T; Yamashita Y; Ninomiya M; Iguchi T; Bekki Y; Shirabe K; Maehara Y
    Transplantation; 2014 Feb; 97(4):457-62. PubMed ID: 24531822
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application of postoperative Model for End-Stage Liver Disease scoring system for evaluating liver graft function after living donor liver transplantation.
    Toshima T; Ikegami T; Kimura K; Harimoto N; Yamashita Y; Yoshizumi T; Soejima Y; Ikeda T; Shirabe K; Maehara Y
    Transplant Proc; 2014; 46(1):81-6. PubMed ID: 24507030
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the updated definition of early allograft dysfunction in donation after brain death and donation after cardiac death liver allografts.
    Croome KP; Wall W; Quan D; Vangala S; McAlister V; Marotta P; Hernandez-Alejandro R
    Hepatobiliary Pancreat Dis Int; 2012 Aug; 11(4):372-6. PubMed ID: 22893463
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors and criteria predicting early graft loss after adult-to-adult living donor liver transplantation.
    Du Z; Wei Y; Chen K; Chen X; Zhang Z; Li H; Ma Y; Li B
    J Surg Res; 2014 Apr; 187(2):673-82. PubMed ID: 24275573
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prediction of early allograft dysfunction using serum phosphorus level in living donor liver transplantation.
    Hong SH; Kwak JA; Chon JY; Park CS
    Transpl Int; 2013 Apr; 26(4):402-10. PubMed ID: 23350888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunotherapy Using Activated Natural Killer Cells Improves Postoperative Neutrophil-to-Lymphocyte Ratio and Long-Term Prognosis of Living Donor Liver Transplant Recipients With Hepatocellular Carcinoma.
    Imaoka K; Ohira M; Hattori M; Chogahara I; Sato S; Nakamura M; Bekki T; Sato K; Imaoka Y; Nakano R; Yano T; Sakai H; Kuroda S; Tahara H; Ide K; Kobayashi T; Tanaka Y; Ohdan H
    Transplant Proc; 2024 Apr; 56(3):634-639. PubMed ID: 38443302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio in predicting survival for patients with stage I-II gastric cancer.
    Sun X; Liu X; Liu J; Chen S; Xu D; Li W; Zhan Y; Li Y; Chen Y; Zhou Z
    Chin J Cancer; 2016 Jun; 35(1):57. PubMed ID: 27342313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neutrophil Lymphocyte Ratio can Preempt Development of Sepsis After Adult Living Donor Liver Transplantation.
    Sarin S; Pamecha V; Sinha PK; Patil N; Mahapatra N
    J Clin Exp Hepatol; 2022; 12(4):1142-1149. PubMed ID: 35814504
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Graft and patient survival after adult live donor liver transplantation compared to a matched cohort who received a deceased donor transplantation.
    Thuluvath PJ; Yoo HY
    Liver Transpl; 2004 Oct; 10(10):1263-8. PubMed ID: 15376301
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Postoperative neutrophil-to-lymphocyte ratio of living-donor liver transplant: Association with graft size.
    Hayashi H; Takamura H; Ohbatake Y; Nakanuma S; Makino I; Nakagawara H; Miyashita T; Tajima H; Fushida S; Ohta T
    Asian J Surg; 2016 Apr; 39(2):103-8. PubMed ID: 26699814
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Lactate-to-Platelet Ratio: A Novel Predictor for Short-Term Early Allograft Failure After Liver Transplantation.
    Takahashi K; Nagai S; Gosho M; Kitajima T; Kim J; Oda T; Abouljoud M
    Transplant Proc; 2021 Dec; 53(10):2993-2999. PubMed ID: 34756715
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protein Profiles of Pretransplant Grafts Predict Early Allograft Dysfunction After Liver Transplantation From Donation After Circulatory Death.
    Xie H; Zhang L; Guo D; Yang Z; Zhu H; Zhou K; Feng X; Wei Q; Xu X; Song P; Wen X; Li J; Liu J; Zheng S
    Transplantation; 2020 Jan; 104(1):79-89. PubMed ID: 31283675
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes in hepatitis C virus-infected recipients of living donor vs. deceased donor liver transplantation.
    Terrault NA; Shiffman ML; Lok AS; Saab S; Tong L; Brown RS; Everson GT; Reddy KR; Fair JH; Kulik LM; Pruett TL; Seeff LB;
    Liver Transpl; 2007 Jan; 13(1):122-9. PubMed ID: 17192908
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Donor information based prediction of early allograft dysfunction and outcome in liver transplantation.
    Hoyer DP; Paul A; Gallinat A; Molmenti EP; Reinhardt R; Minor T; Saner FH; Canbay A; Treckmann JW; Sotiropoulos GC; Mathé Z
    Liver Int; 2015 Jan; 35(1):156-63. PubMed ID: 24351095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.